Transparency

Committed to acting responsibly and ethically

Alimera Sciences Europe Ltd is proud of its collaborations. Working together with the Healthcare Organisations and their staff is vital for improving outcomes for patients and ensuring they receive the best possible care.

Alimera Sciences Europe Ltd fully participates in The Irish Pharmaceutical Healthcare Association IHPA Disclosure IE initiative to increase transparency about the relationships we have with doctors, nurses, pharmacists and other healthcare professionals.

Alimera Sciences Europe Ltd fully adheres to the IPHA code of practice and also our own internal Code of Business Conduct & Healthcare compliance reflecting our commitment to act responsibly and ethically.

Get in touch

European Headquarters

Alimera Sciences Europe Ltd

77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60, Ireland

Product enquiries (Ireland only): 1800 944426
General enquiries: +353 1 5530215

Report an adverse event

If you believe you have experienced any medical side effects from an Alimera Sciences product, please consult your physician or healthcare professional immediately.
Adverse events should also be reported to Alimera Sciences: pvalimerasciences@alimerasciences.com

Report a compliance concern

You may report a compliance concern in any of the following ways, 24 hours a day, 7 days a week:

Website: www.lighthousegoto.com/AlimeraCompliance/eng
Telephone: First enter access code: 1-800-550-000 00-800-222-55288 (UIFN) Then dial toll-free #: 800-603-2869
E-mail: reports@lighthouse-services.com (must refer to Alimera Sciences in the email report)

© 2025 Alimera Sciences Europe Ltd | Terms & Conditions | Privacy Policy

Date of preparation: January 2025. IE-UNB-MMM-0016
We use an analytics cookie to measure website use and to improve visitor experience. We DO NOT use marketing cookies.
By clicking here you can choose to disallow analytics. Only cookies strictly essential for the functioning of our service will remain. Privacy policy.
Date of preparation: March 2021, IE-UNB-MMM-0005